The Global Iohexol Powder Market was valued at US$ 575 Million in 2025 and is projected to reach US$ 942 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period (2024–2030). This significant growth is being driven by the rising global incidence of chronic diseases requiring diagnostic imaging, advancements in CT scan technology, and the expanding access to healthcare in emerging economies.

As the demand for high-quality, safe, and effective contrast agents grows, the role of key manufacturers in ensuring a secure and efficient supply chain becomes paramount. In this blog, we profile the Top 10 Companies in the Iohexol Powder Industry—a group of pharmaceutical giants and specialized chemical producers who are shaping the standards for diagnostic imaging worldwide.

Download FREE Sample Report:
Iohexol Powder Market – View in Detailed Research Report

---

🔟 1. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Omnipaque™ (Iohexol) Active Pharmaceutical Ingredient (API)

GE Healthcare is a global leader in medical imaging and pharmaceuticals, with its Omnipaque™ brand being one of the most widely recognized non-ionic contrast agents. The company controls a significant portion of the iohexol API supply chain, ensuring high-purity powder for formulation into injectable solutions used in millions of diagnostic procedures annually.

Strategic Initiatives:

• Continuous process optimization for high-yield iohexol powder production

• Investment in sustainable manufacturing practices for pharmaceutical intermediates

• Extensive global distribution network serving hospitals and imaging centers

---

9️⃣ 2. Otsuka Chemicals

Headquarters: Osaka, Japan
Key Offering: High-Purity Iohexol Powder (API)

Otsuka Chemicals is a key Japanese manufacturer of fine chemicals and pharmaceutical intermediates, including iohexol powder. The company leverages its strong R&D capabilities to produce high-quality contrast media ingredients that meet stringent international pharmacopeia standards.

Strategic Initiatives:

• Focus on purity and consistency in API manufacturing

• Strategic partnerships with contrast agent formulators in Asia and Europe

---

8️⃣ 3. Justesa Imagen

Headquarters: Madrid, Spain
Key Offering: Iohexol Powder and Contrast Media Solutions

Justesa Imagen specializes in the development, manufacturing, and marketing of contrast media for diagnostic imaging. The company has established itself as a significant player in the European and Latin American markets, with a robust portfolio that includes iohexol-based products.

Strategic Initiatives:

• Expansion of manufacturing capacity to meet growing regional demand

• Investment in new formulations for enhanced patient safety and image quality

---

7️⃣ 4. Starry Pharmaceutical

Headquarters: Wuhan, China
Key Offering: Pharmaceutical Grade Iohexol Powder

Starry Pharmaceutical is a leading Chinese manufacturer focusing on APIs and contrast media. The company has rapidly grown its market share by supplying cost-effective, high-quality iohexol powder to both domestic and international pharmaceutical companies.

Strategic Initiatives:

• Leveraging China’s chemical manufacturing infrastructure for competitive production

• Active pursuit of international regulatory certifications (GMP, FDA, EDQM)

Download FREE Sample Report:
Iohexol Powder Market – View in Detailed Research Report

---

6️⃣ 5. Haichang Pharmaceutical

Headquarters: Zhejiang, China
Key Offering: Iohexol API and Finished Dosage Forms

Haichang Pharmaceutical is another major Chinese producer with a vertically integrated approach to contrast media. The company manufactures iohexol powder and also formulates it into finished injectable products, providing a complete supply chain solution.

Strategic Initiatives:

• Vertical integration from raw materials to finished contrast agents

• Focus on cost-competitive production for emerging markets

---

5️⃣ 6. Sanochemia Pharmazeutika AG

Headquarters: Vienna, Austria
Key Offering: Iohexol and Other Contrast Media APIs

Sanochemia is a European specialist in the development and production of contrast media and neurological pharmaceuticals. The company supplies high-purity iohexol powder to various partners across the globe, with a strong emphasis on quality and regulatory compliance.

Strategic Initiatives:

• Specialization in complex organic synthesis for contrast agents

• Maintenance of high regulatory standards for EU and US markets

---

4️⃣ 7. Tianjin Pacific Chemical & Pharmaceutical Co., Ltd.

Headquarters: Tianjin, China
Key Offering: Iohexol Powder and Intermediates

This company is a significant chemical and pharmaceutical manufacturer in Northern China, producing a range of pharmaceutical intermediates, including those used for iohexol synthesis. It serves as a key supplier to larger contrast media producers.

Strategic Initiatives:

• Production of key intermediates for contrast media synthesis

• Cost leadership in the Asian supply chain

---

3️⃣ 8. Hengrui Medicine

Headquarters: Jiangsu, China
Key Offering: Contrast Media APIs including Iohexol

As one of China’s largest and most innovative pharmaceutical companies, Hengrui Medicine has invested in the production of contrast media APIs. The company’s strong R&D capabilities and manufacturing scale position it as a growing force in the global iohexol market.

Strategic Initiatives:

• Significant investment in R&D for improved contrast agent formulations

• Expansion of international market presence

---

2️⃣ 9. Loba Feinchemie AG

Headquarters: Vienna, Austria
Key Offering: High-Purity Chemicals and Pharmaceutical Intermediates

Loba Feinchemie is a specialist chemical company with expertise in producing fine chemicals for the pharmaceutical industry. The company supplies high-quality intermediates that are critical for the synthesis of complex molecules like iohexol.

Strategic Initiatives:

• Focus on niche, high-value chemical intermediates

• Long-standing relationships with major pharmaceutical companies

---

1️⃣ 10. Alkali Metals Ltd.

Headquarters: Hyderabad, India
Key Offering: Iohexol Intermediates and Custom Synthesis

Alkali Metals is an Indian company specializing in the custom synthesis of complex organic molecules. It provides key intermediates for the production of iohexol, leveraging India’s strengths in chemical manufacturing and process development.

Strategic Initiatives:

• Custom synthesis services for pharmaceutical companies

• Competitive cost structure for intermediate manufacturing

Get Full Report Here:
Iohexol Powder Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Iohexol Powder Is Driven by Diagnostic Precision and Safety

The iohexol powder market is evolving in response to the increasing sophistication of medical imaging and the global emphasis on patient safety. While the core chemical remains a standard of care, manufacturers are focusing on ultra-high purity, sustainable production, and secure supply chains.

📈 Key Trends Shaping the Market:

• Increasing demand for high-purity (>99.5%) iohexol powder to minimize adverse reactions

• Supply chain diversification and regionalization post-pandemic

• Growing adoption of CT imaging in emerging economies for disease diagnosis

• Regulatory emphasis on robust quality control and traceability in API manufacturing

Get Full Report Here:
Iohexol Powder Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical medical ingredient—they are enabling the accurate diagnosis and treatment of millions of patients worldwide.